Perspective Therapeutics earnings were -$85.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CATX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$18.2M, down 54.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CATX reported annual earnings of -$79.3M, with 70.5% growth.
Perspective Therapeutics Earnings Reports & History FAQ
What were Perspective Therapeutics's earnings last quarter?
Perspective Therapeutics (NYSEMKT: CATX) reported Q1 2025 earnings per share (EPS) of -$0.25, up 0% year over year. Total CATX earnings for the quarter were -$18.18 million. In the same quarter last year, Perspective Therapeutics's earnings per share (EPS) was -$0.25.
Is Perspective Therapeutics profitable or losing money?
As of the last Perspective Therapeutics earnings report, Perspective Therapeutics is currently losing money. Perspective Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$85.17 million, a 45.79% increase year over year.
What was CATX's earnings growth in the past year?
As of Perspective Therapeutics's earnings date in Q2 2025, Perspective Therapeutics's earnings has grown year over year. CATX earnings in the past year totalled -$85.17 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.